xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

338

KUANetal.

TABLE XXX.1 (Continued)

Clinical endpoints Validate the QOL

Study

Year LOE Study design Study groups

Conclusion

Loet al. 2087

The Chinese version of the QOL-RTI/H&N survey is a reliable and valid tool for measuring QOL in Chinese patients with H&N cancer

2004 2

Cross-sectional study

Chinese patients with head and neck cancer ( n = 138) ∙ Nasopharynx ( n = 106) ∙ Paranasal sinus ( n = 8) ∙ Nonsinonasal ( n = 24)

RTI/H&N for Chinese patients with Head&Neck cancerwho were treated with radiation therapy instrument to measure QOL inCuban patients with head and neck cancer Quality of Life inCancer Patients survey specific to patients withNPCin the Chinese

Lugo-Alonso et al. 2084

2017 3

Cross-sectional study

Cuban patients with head and neck cancer

Construct and validate an

The 65 item CV-IOR-CyC-01 survey has good validity and interpretability in the Cuban population with head and neck cancer

( n = 520) ∙ Oral or

mesopharyngeal cancer ( n = 270) ∙ Laryngeal cancer ( n = 228) ∙ NPC( n = 22) Chinese patients with NPC( n = 121)

Wuet al. 2083

The QLICP-NA V2.0 has some validity, reliability, and responsiveness but needs improvements before being applied broadly in Chinese patients with NPC

2016 3

Cross-sectional study

Develop and validatea

population (QLICP-NA V2.0)

tenDam

2018 3

Prospective cohort

Patients with paranasal sinus and skull base pathology ( n = 100). ∙ Anterior skull base: pituitary adenoma ( n = 28) ∙ Paranasal sinus pathology: CRS, mucocele, IP ( n = 72) Patients undergoing EEA for sinonasal and skull base pathology ∙ Sinus pathology ( n = 207) ∙ CRS ( n = 165) ∙ Anterior skull base pathology ( n = 93)

Evaluate the test-retest reliability, construct

The EES-Q is a reliable and acceptable disease specific tool for HRQoL assessment after endoscopic endonasal sinus or anterior skull base surgery

et al. 2072

validity and responsive ness of the EES-Q

A 30-item EES-Q was developed with high internal consistency for all three HRQoL domains

tenDam

2017 3

Prospective cohort

Develop a multi dimensional disease specific HRQoL instrument for patients undergoing EEA to assess nasal morbidity after treatment

et al. 2071

(Continues)